Search
Nasus Pharma Ltd
NSRXAdd to Watchlist
3.640USD
+0.070+1.96%
Close 09-23 16:00（ET）
42.62MMarket Cap
LossP/E TTM
NSRX Analyst Recommendation Trends
In the current month, NSRX has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. NSRX average Analyst price target in the last month is 19.667.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.53
-0.23
-0.23
--
-0.58
Actual
--
--
--
--
--
Surprise
--
--
--
--
--
FAQs
What is the analyst rating for Nasus Pharma Ltd?
Based on the ratings of Nasus Pharma Ltd's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.